GSK, Empirico collaborate for oligonucleotide candidate to treat respiratory diseases
GSK and Empirico Collaborate on Oligonucleotide Candidate GSK plc and Empirico Inc. have entered into a worldwide exclusive license agreement for EMP-012, a highly selective siRNA oligonuc…